lercea oral glp-1 reviews What's next in the pipeline? Prime's clinical team shares the latest - Prime Therapeutics GLP-1 for Weight Loss: How
Description
Mounjaro is approved in the EU for both indications treating type 2 diabetes and, as of 2024, for weight loss in qualifying patients [1][17]
Prieto as one of her Concierge patients
Originally developed for type 2 diabetes, these prescription medications are now also approved for chronic weight management in certain individuals
The following strategies can help patients tolerate treatment and reduce the likelihood of complications: Gradual dose escalation is fundamental to tolerability
